Pancretic Dissease (Benign/Malignancy)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pancretic Dissease (Benign/Malignancy) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 3

NCT05551832

Prevalence of Marginal Ulcer After PPPD and Preventive Effect of Proton Pump Inhibitor in Korea: A Prospective Multicent…

This research is to determine which medication, Esmesol (PPI) or Placebo works best at reducing the chance that a patient will get an marginal ulcer after pancr…

South Korea360 participantsStarted 2022-10-10

Treatment: Arm I (Placebo),, Arm II (ESMESOL)